Docetaxel for Pembrolizumab‐Refractory Recurrent Basal Cell Carcinoma
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Misaki Kase (ORCID: https://orcid.org/0009-0008-6792-2372)
- Harutaka Seshimo (ORCID: https://orcid.org/0000-0001-7601-1732)
- Dai Ogata (ORCID: https://orcid.org/0000-0002-1335-7100)
- Kenjiro Namikawa
- Michitoshi Kurisaki (ORCID: https://orcid.org/0009-0003-1566-1274)
- Naoya Yamazaki
- Eiji Nakano
- Yoshiki Sakai
- Yuta Kage
Institutions
- University of Miyazaki (JP)
Publication Details
- Journal
- The Journal of Dermatology
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1111/1346-8138.70244
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00